Edwards Lifesciences Corp (EW)vsZimmer Biomet Holdings Inc (ZBH)
EW
Edwards Lifesciences Corp
$82.67
+1.20%
HEALTHCARE · Cap: $48.01B
ZBH
Zimmer Biomet Holdings Inc
$87.64
+1.53%
HEALTHCARE · Cap: $17.11B
Smart Verdict
WallStSmart Research — data-driven comparison
Zimmer Biomet Holdings Inc generates 36% more annual revenue ($8.23B vs $6.07B). EW leads profitability with a 17.7% profit margin vs 8.6%. ZBH appears more attractively valued with a PEG of 0.60. ZBH earns a higher WallStSmart Score of 59/100 (C).
EW
Buy55
out of 100
Grade: C
ZBH
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-544.4%
Fair Value
$12.31
Current Price
$82.67
$70.36 premium
Margin of Safety
-296.1%
Fair Value
$24.14
Current Price
$87.64
$63.50 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 23.7%
Reasonable price relative to book value
Growing faster than its price suggests
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 76.6%
ROE of 5.6% — below average capital efficiency
Weak financial health signals
Earnings declined 40.8%
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin. Profitability is solid with margins at 17.7% and operating margin at 23.7%. Revenue growth of 13.3% demonstrates continued momentum.
Bull Case : ZBH
The strongest argument for ZBH centers on Price/Book, PEG Ratio. Revenue growth of 10.9% demonstrates continued momentum. PEG of 0.60 suggests the stock is reasonably priced for its growth.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 45.7x leaves little room for execution misses.
Bear Case : ZBH
The primary concerns for ZBH are Return on Equity, Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
EW profiles as a mature stock while ZBH is a value play — different risk/reward profiles.
EW carries more volatility with a beta of 0.93 — expect wider price swings.
EW is growing revenue faster at 13.3% — sustainability is the question.
ZBH generates stronger free cash flow (366M), providing more financial flexibility.
Bottom Line
ZBH scores higher overall (59/100 vs 55/100) and 10.9% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Zimmer Biomet Holdings Inc
HEALTHCARE · MEDICAL DEVICES · USA
Zimmer Biomet is a publicly traded medical device company. The company is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?